NCT04886804: Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Neoplasm Metastasis, Non-Small Cell Lung Cancer